Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

460
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
460
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

586
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
586
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

640
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
640
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

621
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
621

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative-Pressure Lung Re-expansion After One-Lung Ventilation for Pulmonary Resection: A Retrospective Study.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Real time monitoring of hydrogenotrophic methanogenesis under deep saline aquifers conditions.

Journal of biological engineering·2026
Same author

A microfluidic platform for studying supercritical fluid crystallization and its applications.

Lab on a chip·2025
Same author

Post-oesophagectomy hiatal hernia.

Multimedia manual of cardiothoracic surgery : MMCTS·2025
Same author

Pulmonary sequestration 2: left lower lobe.

Multimedia manual of cardiothoracic surgery : MMCTS·2025
Same author

Pulmonary sequestration 1: right lower lobe.

Multimedia manual of cardiothoracic surgery : MMCTS·2025

Related Experiment Video

Updated: Apr 30, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

11.4K

Survival post surgery for malignant pericardial effusion.

Olivier Nguyen1, Denise Ouellette2

  • 1Faculty of Surgery, University of Montreal;

Clinics and Practice
|April 26, 2014
PubMed
Summary

Subxiphoid pericardial window procedures offer limited palliation for malignant pericardial effusion, particularly in lung cancer patients. This intervention does not improve long-term survival rates.

Keywords:
malignant diseasepericardial effusionsubxiphoid window.

More Related Videos

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K

Related Experiment Videos

Last Updated: Apr 30, 2026

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

11.4K
An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.2K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

3.7K

Area of Science:

  • Oncology
  • Cardiothoracic Surgery
  • Palliative Care

Background:

  • Malignant pericardial effusion is a serious complication of advanced cancers.
  • The subxiphoid pericardial window is a surgical option for managing malignant pericardial effusion.

Observation:

  • This retrospective study reviewed 60 patients with malignant pericardial effusion treated with a subxiphoid pericardial window between 1994 and 2008.
  • Lung cancer was the most common primary malignancy (72%).

Findings:

  • The 30-day mortality rate was 31%.
  • Median survival was 2.6 months, with 2-year survival at 9%.
  • The procedure provided short-term symptom relief but did not impact long-term survival.

Implications:

  • Subxiphoid pericardial window offers palliative benefits but not curative for malignant pericardial effusion.
  • Treatment decisions for malignant pericardial effusion should weigh surgical palliation against non-surgical options based on individual patient factors.
  • Further research may explore optimizing palliative strategies for advanced malignancy with pericardial effusion.